Anti-Adeno-Associated Virus, Intact Particles, Mouse-Mono(A20) <Anti-AAV>

データシート

• 商品コード：61055
• メーカー：POG
• 包装：50μg
• 価格： ¥128,000
• 在庫：1個

マイリストに追加 マイリストに追加済

• No.： 1
• 文献情報：
  Jin LF et al. Ultrasound targeted microbubble destruction stimulates cellular endocytosis in facilitation of adeno-associated virus delivery. Int J Mol Sci 2013;14(5):9737-50
  Jin LF et al
  2013/01/01
  
• 備考：
  
• 参照：
  

• No.： 2
• 文献情報：
  Mietzsch M et al. OneBac: platform for scalable and high-titer production of adeno-associated virus serotype 1-12 vectors for gene therapy. Hum. Gene Ther. 2014 Mar;25(3):212-22
  Mietzsch M et al
  2014/01/01
  
• 備考：
  
• 参照：
  

• No.： 3
• 文献情報：
  Moskalenko M et al. Epitope mapping of human anti-adeno-associated virus type 2 neutralizing antibodies: implications for gene therapy and virus structure. J. Virol. 2000 Feb;74(4):1761-6
  Moskalenko M et al
  2000/01/01
  
• 備考：
  
• 参照：
  

• No.： 4
• 文献情報：
  Bartlett JS et al. Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab&quot;gamma)2 antibody. Nat. Biotechnol. 1999 Feb;17(2):181-6
  Bartlett JS et al
  1999/01/01
  
• 備考：
  
• 参照：
  

• No.： 5
• 文献情報：
  Grimm D et al. Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2. Gene Ther. 1999 Jul;6(7):1322-30
  Grimm D et al
  1999/01/01
  
• 備考：
  
• 参照：
  

• No.： 6
• 文献情報：
  Wobus CE et al. Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection. J. Virol. 2000 Oct;74(19):9281-9
  Wobus CE et al
  2000/01/01
  
• 備考：
  
• 参照：
  

• No.： 7
• 文献情報：
  Wistuba A et al. Subcellular compartmentalization of adeno-associated virus type 2 assembly. J. Virol. 1997 Feb;71(2):1341-52
  Wistuba A et al
  1997/01/01
  
• 備考：
  
• 参照：
  

• No.： 8
• 文献情報：
  Naumer M et al. Properties of the adeno-associated virus assembly-activating protein. J. Virol. 2012 Dec;86(23):13038-48
  Naumer M et al
  2012/01/01
  
• 備考：
  
• 参照：
  

• No.： 9
• 文献情報：
  Sonntag F et al. The assembly-activating protein promotes capsid assembly of different adeno-associated virus serotypes. J. Virol. 2011 Dec;85(23):12686-97
  Sonntag F et al
  2011/01/01
  
• 備考：
  
• 参照：
  

• No.： 10
• 文献情報：
  Wistuba A et al. Intermediates of adeno-associated virus type 2 assembly: identification of soluble complexes containing Rep and Cap proteins. J. Virol. 1995 Sep;69(9):5311-9
  Wistuba A et al
  1995/01/01
  
• 備考：
  Applications (Species): IP (AAV2)
• 参照：
  

• No.： 11
• 文献情報：
  Mietzsch, M. et al. OneBac: Platform for Scalable and High-Titer Production of Adeno-Associated Virus Serotype 1-12 Vectors for Gene Therapy. Hum. Gene Ther. 25, 212-222 (2014).
  
  
• 備考：
  species: AAV2, application: ICC-IF
• 参照：
  

• No.： 12
• 文献情報：
  Moskalenko, M. et al. Epitope Mapping of Human Anti-Adeno-Associated Virus Type 2 Neutralizing Antibodies: Implications for Gene Therapy and Virus Structure. Jounal Virol. 74, 1761-1766 (2000).
  
  
• 備考：
  species: AAV2, application: neutralization assay
• 参照：
  

• No.： 13
• 文献情報：
  Grimm, D. et al. Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2. Gene Ther. 6, 1322-30 (1999).
  
  
• 備考：
  species: AAV2, application: ELISA
• 参照：
  

• No.： 14
• 文献情報：
  Bartlett, J. S., Kleinschmidt, J., Boucher, R. C. and Samulski, R. J. Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab&quot;gamma)2 antibody. Nat. Biotechnol. 17, 181-6 (1999).
  
  
• 備考：
  species: AAV2
• 参照：
  

• No.： 15
• 文献情報：
  Wistuba, A. et al. Subcellular Compartmentalization of Adeno-Associated Virus Type 2 Assembly. J. Virol. 71, 1341-1352 (1997).
  
  
• 備考：
  species: AAV2, application: ICC-IF, IP
• 参照：
  

• No.： 16
• 文献情報：
  Wistuba, A., Weger, S., Kern, A., Rgen, J. and Kleinschmidt, A. Intermediates of Adeno-Associated Virus Type 2 Assembly: Identification of Soluble Complexes Containing Rep and Cap Proteins. J. Virol. 69, 5311-5319 (1995).
  
  
• 備考：
  species: AAV2, application: IP
• 参照：
  

• No.： 17
• 文献情報：
  Haar J et al. MSD-based assays facilitate a rapid and quantitative serostatus profiling for the presence of anti-AAV antibodies. Mol Ther Methods Clin Dev 2022 Jun;25:360-369
  Haar J et al
  2022/01/01
  
• 備考：
  
• 参照：
  

• No.： 18
• 文献情報：
  Earley LF et al. Adeno-associated Virus (AAV) Assembly-Activating Protein Is Not an Essential Requirement for Capsid Assembly of AAV Serotypes 4, 5, and 11. J. Virol. 2017 Feb;91(3)
  Earley LF et al
  2017/01/01
  
• 備考：
  
• 参照：
  

• No.： 19
• 文献情報：
  Lochrie MA et al. Mutations on the external surfaces of adeno-associated virus type 2 capsids that affect transduction and neutralization. J Virol 2006 Jan;80(2):821-34
  Lochrie MA et al
  2006/01/01
  
• 備考：
  
• 参照：
  

• No.： 20
• 文献情報：
  Hamann MV et al. Improved targeting of human CD4+ T cells by nanobody-modified AAV2 gene therapy vectors. PLoS One 2021;16(12):e0261269
  Hamann MV et al
  2021/01/01
  
• 備考：
  
• 参照：
  

• No.： 21
• 文献情報：
  Emmanuel SN et al. Parvovirus Capsid-Antibody Complex Structures Reveal Conservation of Antigenic Epitopes Across the Family. Viral Immunol 2021;34(1):3-17
  Emmanuel SN et al
  2021/01/01
  
• 備考：
  
• 参照：
  

• No.： 22
• 文献情報：
  Bennett, A. et al. Structure comparison of the chimeric AAV2.7m8 vector with parental AAV2. J. Struct. Biol. 209, 107433 (2020).
  
  
• 備考：
  
• 参照：
  

• No.： 23
• 文献情報：
  Jin, L.-F. et al. Ultrasound Targeted Microbubble Destruction Stimulates Cellular Endocytosis in Facilitation of Adeno-Associated Virus Delivery. Int. J. Mol. Sci 14, 9737–9750 (2013).
  
  
• 備考：
  
• 参照：
  

• No.： 24
• 文献情報：
  Tseng YS et al. Mapping the AAV Capsid Host Antibody Response toward the Development of Second Generation Gene Delivery Vectors. Front Immunol 2014;5:9
  Tseng YS et al
  2014/01/01
  
• 備考：
  
• 参照：
  

• No.： 25
• 文献情報：
  Huttner NA et al. Genetic modifications of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies. Gene Ther 2003 Dec;10(26):2139-47
  Huttner NA et al
  2003/01/01
  
• 備考：
  
• 参照：
  

• No.： 26
• 文献情報：
  McCraw DM et al. Structure of adeno-associated virus-2 in complex with neutralizing monoclonal antibody A20. Virology ;431(1-2):40-9
  McCraw DM et al
  
• 備考：
  
• 参照：
  

• No.： 27
• 文献情報：
  McCraw, D. M., O’Donnell, J. K., Taylor, K. A., Stagg, S. M. & Chapman, M. S. Structure of adeno-associated virus-2 in complex with neutralizing monoclonal antibody A20. Virology 431, 40–49 (2012).
  
  
• 備考：
  
• 参照：